These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3987273)

  • 1. Deep vein thrombosis and the oestrogen content in oral contraceptives. An epidemiological analysis.
    Kierkegaard A
    Contraception; 1985 Jan; 31(1):29-41. PubMed ID: 3987273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and deep venous thrombosis with pulmonary embolism.
    Bouché RT; Medawar SJ; Dockery GL
    J Foot Surg; 1982; 21(4):297-301. PubMed ID: 7186920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content.
    Böttiger LE; Boman G; Eklund G; Westerholm B
    Lancet; 1980 May; 1(8178):1097-101. PubMed ID: 6103437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs.
    Inman WH; Vessey MP; Westerholm B; Engelund A
    Br Med J; 1970 Apr; 2(5703):203-9. PubMed ID: 5443406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side and site of deep vein thrombosis in women using oral contraceptives.
    Kierkegaard A
    Acta Obstet Gynecol Scand; 1985; 64(5):399-402. PubMed ID: 4061060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
    Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives and vascular thrombosis.
    Andrews WC
    South Med J; 1977 May; 70(5):519-20. PubMed ID: 323987
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inferior caval thrombosis and pulmonary thromboembolism as complications due to the use of oral hormonal contraceptives].
    Koroleva IM; Dolgushina LM
    Vestn Rentgenol Radiol; 2004; (4):47-9. PubMed ID: 15626235
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between vascular headaches and low-dose oral contraceptives.
    Karsay K
    Ther Hung; 1990; 38(4):181-5. PubMed ID: 2094059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial changes in plasma fibrinogen concentration and fibrinolytic activity in African women on oral contraceptive pills.
    Famodu AA
    Afr J Reprod Health; 1997 Sep; 1(2):90-5. PubMed ID: 10214418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid contraceptives: neuro-psychiatric & electroencephalographic complications.
    Elwan O; Madkour O; Kamal I; Abdallah M
    J Int Med Res; 1973; 1(6):534-47. PubMed ID: 4806735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Effort thrombosis" of the subclavian vein associated with oral contraceptives.
    Stricker SJ; Sowers DK; Sowers JR; Sirridge MS
    Ann Emerg Med; 1981 Nov; 10(11):596-9. PubMed ID: 7316265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol.
    Goldzieher JW
    J Reprod Med; 1983 Jan; 28(1 Suppl):53-6. PubMed ID: 6403700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic study of blood in women who had used oral contraceptives.
    Fridrichová I
    Neoplasma; 1990; 37(5):545-53. PubMed ID: 1700312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hypertension and oral contraceptives: four cases, with two due to the 30 micrograms oestrogen pill.
    Hodsman GP; Robertson JI; Semple PF; Mackay A
    Eur Heart J; 1982 Jun; 3(3):255-9. PubMed ID: 6809465
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral contraception and thromboembolism: the role of progestogens.
    N Z Med J; 1980 Aug; 92(665):98, 101. PubMed ID: 6933346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-generation oral contraceptives and venous thrombosis.
    Vandenbroucke JP; Helmerhorst FM; Bloemenkamp KW; Rosendaal FR
    Lancet; 1997 Mar; 349(9053):731; author reply 732-3. PubMed ID: 9078225
    [No Abstract]   [Full Text] [Related]  

  • 20. The critical oestrogen content of combined oral contraceptives.
    Mumford JP
    J Int Med Res; 1975; 3(6):407-12. PubMed ID: 1228040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.